LMO3 and meningioma: Homeobox protein Hox-B3 (HOXB3), LIM domain only protein 3 (LMO3), Homeobox protein Hox-B6 (HOXB6), Homeobox protein Hox-A3 (HOXA3) and DNA-binding protein inhibitor ID-2 (ID2) showed higher under-expression in benignB with respect benignA meningiomas with a fold change lower than −3.